Results per Page:
Towards accessible gene therapy: in vivo base editing to cure Sickle Cell Disease
From the Cancer Consortium Lieber Lab, Department of Laboratory Medicine and Pathology, University of Washington
What's new in blood diseases
Four things to watch from the 2016 annual meeting of the American Society of Hematology
CRISPR and beyond: The ins and outs of gene editing and its potential for cures
The big 4 gene-editing platforms and how they could usher in new therapies for HIV, cancer — and other diseases
Filling the halls of Hutch High
Aspiring scientists get firsthand lab experience
Breaking the Silence
Discovery could lead to new treatments for cancer, sickle-cell anemia